Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Hikal Ltd

NSE: HIKAL · BSE: 524735 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹224.24
Market cap
₹2,765 Cr
Revenue (annual)
₹1,713 Cr
Net profit (annual)
₹-48.80 Cr
P/E (TTM)
-81.8×Sector 47.4×
Promoter holding
68.85%+0.00% QoQ
FII holding
0.98%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:24 IST BSE
Other Announcement

Hikal Other Announcement

Hikal Ltd has filed its Business Responsibility and Sustainability Report for FY 2025-26, fulfilling regulatory compliance requirements under SEBI (LODR) Regulations, 2015.

17:25 IST BSE
Other Announcement

Hikal Other Announcement

Hikal Ltd. has been awarded the EcoVadis Gold Medal for its sustainability performance, placing the company in the top 5% of companies assessed by EcoVadis globally.

14:16 IST BSE
Other Announcement

Hikal Other Announcement

Hikal Ltd filed its quarterly shareholding pattern. The disclosure includes a conversion of Castilia Life Sciences Private Limited into an LLP.

14:55 IST BSE
Other Announcement

Hikal Other Announcement

Hikal Ltd submitted its quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent, MUFG Intime India, confirmed that security certificates received for dematerialisation were processed and listed on the exchanges within prescribed timelines.

Execution
quarter ended March 31, 2026